Terms: = Endocrine gland cancer AND CEACAM5, CEA AND Prognosis
269 results:
1. A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma.
Tang H; Miao X; Yu C; Chai C; Su Y; Li L; Yi J; Ye Z; Miao L; Wang Z; Zhang H; Xu H; Zhou W
Sci Rep; 2024 Apr; 14(1):9259. PubMed ID: 38649719
[TBL] [Abstract] [Full Text] [Related]
2. Expression and clinical value of CXCR4 in high grade gastroenteropancreatic neuroendocrine neoplasms.
Pang C; Li Y; Shi M; Fan Z; Gao X; Meng Y; Liu S; Gao C; Su P; Wang X; Zhan H
Front Endocrinol (Lausanne); 2024; 15():1281622. PubMed ID: 38524630
[TBL] [Abstract] [Full Text] [Related]
3. Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic cancer: A Multicenter Cohort Study.
Huang J; Gao G; Ge Y; Liu J; Cui H; Zheng R; Wang J; Wang S; Go VL; Hu S; Liu Y; Yang M; Sun Y; Shang D; Tian Y; Zhang Z; Xiang Z; Wang H; Guo J; Xiao GG
Dig Dis Sci; 2024 Apr; 69(4):1263-1273. PubMed ID: 38451429
[TBL] [Abstract] [Full Text] [Related]
4. Measuring discrepancies between simple medullary and synchronous medullary/papillary thyroid carcinomas: a comparative cross-sectional study.
Zhang D; Yang M; Frattini F; Cestari A; Li K; Wang H; Chi H; Sui C; Bai K; Lan D; Dionigi G; Sun H
Front Endocrinol (Lausanne); 2023; 14():1301200. PubMed ID: 38317715
[TBL] [Abstract] [Full Text] [Related]
5. The emerging roles of ceaCAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic Effect of Preoperative Inflammatory Markers on Morbidity and Overall Survival in Pancreatic Adenocarsinoma.
Çaparlar MA; Durhan A; Süleymanov M; Binarbaşı C; Koşmaz K
Niger J Clin Pract; 2023 Dec; 26(12):1902-1909. PubMed ID: 38158359
[TBL] [Abstract] [Full Text] [Related]
7. Cyst fluid glycoproteins accurately distinguishing malignancies of pancreatic cystic neoplasm.
Cui M; Hu Y; Zhang Z; Chen T; Dai M; Xu Q; Guo J; Zhang T; Liao Q; Yu J; Zhao Y
Signal Transduct Target Ther; 2023 Oct; 8(1):406. PubMed ID: 37848412
[TBL] [Abstract] [Full Text] [Related]
8. Elevated CA 19-9 is associated with worse survival in patients with resected ampullary adenocarcinoma.
Boyev A; Prakash LR; Chiang YJ; Newhook TE; Bruno ML; Arvide EM; Dewhurst WL; Kim MP; Ikoma N; Lee JE; Snyder RA; Tzeng CD; Katz MHG; Maxwell JE
Surg Oncol; 2023 Dec; 51():101994. PubMed ID: 37742542
[TBL] [Abstract] [Full Text] [Related]
9. Preoperative neck ultrasound combined with pathological data can significantly impact the outcome of medullary thyroid carcinoma.
Deandrea M; Piticchio T; Mormile A; Retta F; Canale G; Caracciolo A; Daniele L; Trimboli P
Endocr J; 2023 Nov; 70(11):1061-1067. PubMed ID: 37690841
[TBL] [Abstract] [Full Text] [Related]
10. Elastic modulus-reflected liver lesion stiffness relates to worse prognosis in pancreatic cancer patients with liver metastasis.
Dong S; Miao X; Zhang K; Zhu X; Gao Y; Chen H
World J Surg Oncol; 2023 Aug; 21(1):262. PubMed ID: 37620975
[TBL] [Abstract] [Full Text] [Related]
11. Diagnostic and Prognostic Performance of MicroRNA-25, Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 125 in Pancreatic Ductal Adenocarcinoma.
Gong Y; Song L; Ou L; Lu YY; Huang X; Zeng Q
Iran J Med Sci; 2023 Jul; 48(4):401-413. PubMed ID: 37456201
[TBL] [Abstract] [Full Text] [Related]
12. Intraductal oncocytic papillary neoplasm of the pancreas: clinical and radiological features compared to those of intraductal papillary mucinous neoplasm.
Nakaya M; Nakai Y; Takahashi M; Fukukura Y; Sato K; Kameda A; Tashiro Y; Kageyama S; Sofue K; Nakano T; Yoshimitsu K; Marugami N; Takeyama N; Tanaka M; Hasegawa K; Watadani T
Abdom Radiol (NY); 2023 Aug; 48(8):2483-2493. PubMed ID: 37358603
[TBL] [Abstract] [Full Text] [Related]
13. Significance of multiple tumor markers measurements in conversion surgery for unresectable locally advanced pancreatic cancer.
Nagai M; Nakamura K; Terai T; Kohara Y; Yasuda S; Matsuo Y; Doi S; Sakata T; Sho M
Pancreatology; 2023 Sep; 23(6):721-728. PubMed ID: 37328387
[TBL] [Abstract] [Full Text] [Related]
14. Can combined use of tumor markers in pancreatic cancer be a solution to short- and long-term consequences?: A retrospective study.
Esen E; Aslan M; Morkavuk SB; Azili C; Ersoz S; Bahcecioglu IB; Unal AE
Medicine (Baltimore); 2023 Mar; 102(11):e33325. PubMed ID: 36930073
[TBL] [Abstract] [Full Text] [Related]
15. [Hereditary medullary thyroid cancer].
Fendrich V; Zahn A
Chirurgie (Heidelb); 2023 May; 94(5):393-399. PubMed ID: 36799965
[TBL] [Abstract] [Full Text] [Related]
16. Diagnostic role and prognostic value of tumor markers in high-grade gastro-enteropancreatic neuroendocrine neoplasms.
Gao C; Fan Z; Yang J; Shi M; Li Y; Zhan H
Pancreatology; 2023 Mar; 23(2):204-212. PubMed ID: 36710224
[TBL] [Abstract] [Full Text] [Related]
17. Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
Hu Y; Fu K; Liu H; He Q; Qiu X; Yang W; Zhang Y
J Ovarian Res; 2023 Jan; 16(1):18. PubMed ID: 36670456
[TBL] [Abstract] [Full Text] [Related]
18. Other markers of medullary thyroid cancer, not only calcitonin.
Censi S; Manso J; Mian C
Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651167
[TBL] [Abstract] [Full Text] [Related]
19. Laparoscopic Radical Antegrade Modular Pancreatosplenectomy via Dorsal-Caudal Artery Approach for Pancreatic Neck-Body cancer.
Shen Z; Chen G; Zhu C; Wu X; Liu Y; Liu Z; Tan Z; Zhong X
J Vis Exp; 2022 Nov; (189):. PubMed ID: 36468699
[TBL] [Abstract] [Full Text] [Related]
20. Primary leiomyosarcoma of ovary: A rare malignancy as an incidental finding.
Raychaudhuri S; Sidam D; Jain M; Chawla R; Pujani M; Wadhwa R
Indian J Pathol Microbiol; 2022; 65(4):938-941. PubMed ID: 36308213
[TBL] [Abstract] [Full Text] [Related]
[Next]